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Objectives: The extent and mechanism of cross-infection with Pseudomonas aeru-
ginosa (PA) in specialist cystic ﬁbrosis (CF) units remain controversial. Prevention
of droplet spread by segregation and use of single patient rooms is advised by
most authorities. Despite these measures, many centres continue to report outbreaks
of clonal “epidemic” strains. We conducted an aerobiological study to examine
airborne dispersal of PA in a large CF centre in the UK.
Methods: Microbiological air sampling was conducted in outpatient and inpatient
areas inhabited by patients known to harbour the Liverpool Epidemic Strain (LES)
of PA. A volumetric air sampler was placed at least 1m from patients, working
at a rate of 100 L/min with a sampling time of 10min. Any colonies growing on
Pseudomonas selective agar were identiﬁed by phenotypic and molecular methods
and the number of colony-forming units (CFUs) counted.
Conclusion: Out of 177 samples obtained from 8 separate patient environments,
33 (19%) grew PA. Contamination was greater in patient rooms than corridor areas;
23% (29/125) vs 10% (4/51) respectively. Rooms inhabited by 3 of 8 patients
yielded positive growth. Corridor air was positive in the vicinity of 1 patient’s
closed room. Samples from this patient’s room demonstrated much higher counts
than those from other rooms (mean 61CFU/m3 vs 0−3CFU/m3). These data
conﬁrm that PA can contaminate air >1m from patients and suggest that certain
patients may act as “super-shedders”. Ventilation strategies and infection control
precautions in CF centres should take into account the possibility of true airborne
transmission of PA.
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In a cross-sectional study in 2007, we investigated the population structure of
Pseudomonas aeruginosa (PA) in 596 (46%) cystic ﬁbrosis (CF) patients in the
Netherlands. PA carriage in the respiratory tract of all CF patients visiting two major
CF centres was determined by standard microbiological techniques, and all obtained
phenotypically different isolates in the ﬁrst positive culture were typed with multi
locus sequence typing (MLST). Of 265 PA positive patients 60% harboured a strain
found in at least 2 other patients. ST406 was found in 15% of the patients colonised
with PA, mainly among patients 15−25 yrs of age. ST406 is not genetically linked
to other international epidemic clones.
In this follow-up 2011 study we investigated the effects of segregating CF patients
(which started in 2006) on the population structure of PA in CF patients and
persistence of sequence types (STs), using identical methodology as in the previous
study.
PA was detected in 52% of the 621 cultured patients and from 280 patients with PA
(86%), 414 isolates were genotyped. This yielded 157 STs. STs shared between
more than two patients were found in 50% of patients. ST406, the prevalent
clone, was found in 14% of patients with a higher average age compared to 2007
(20−30 yrs). In >90% of the patients that were included in both studies (157)
genotypes persisted.
The combined data of two cross-sectional studies in 2007 and 2011 demonstrate
that the population structure of PA is highly diverse with >90% persistence of
strains in individual patients during four years. The observed association between
age and presence of ST406 seems a cohort phenomenon rather than age-related
niche adaptation.
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Objectives: Pseudomonas aeruginosa cluster A (Variable Number Tandem Repeat
proﬁle 8, 3, 4, 5, 2, 3, 5, 2, x, where the repeat number at the last, most discriminatory
locus is variable) or ST27 was ﬁrst reported in UK CF patients by our group at the
ECFS conference in 2011. Between June 2010 and June 2012 we received P. aeru-
ginosa isolates from approximately 1204 CF patients and 1026 non-CF patients for
molecular comparison. Within this time, cluster A was isolated from approximately
5% (n = 61) of CF patients from 26 hospitals in the UK, as opposed to from 1%
(n = 10) non-CF patients, suggesting a propensity for the CF lung. We aimed to
examine the clinical relevance of this strain in CF.
Methods: A simple questionnaire was submitted to clinicians requesting infor-
mation regarding the affected patients’ general health (co-morbidities, numbers
of exacerbations and co-infections), in addition to speciﬁc questions regarding
this strain (estimated time of infection, whether the patient was considered to be
chronically infected, and the possible source of infection). The information received
back from hospitals was correlated with PCR assay results for the presence or
absence of seven accessory genes, permitting examination of isolates from patients
attending the same hospital for any evidence of cross-infection.
Conclusion: In the majority of cases these combined data suggested this strain was
being acquired independently by CF patients attending the same hospital, rather
than through cross-infection. In addition, the evidence suggested that this strain is
not thought to be especially pathogenic to CF patients.
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Objectives: Prevention of PA cross infection among patients is mandatory for
CF Centers. In order to reduce this risk, in our Center patients are categorized
into negative, intermittent, and chronic infection groups. During 2011 we noted the
ﬁrst isolation of PA in 5 children aged less than 24mo. This study was carried out
to clarify if a cross infection happened.
Methods: Ten PA strains were isolated and subtyped by automated ribotyping
with DuPont Qualicon RiboPrinter® system using the enzyme EcoRI; in order
to obtain dendrogram, generated results were analyzed by software Bionumerics
v.6.6 (Applied Maths).
Results: The majority of strains have no genetic homology, due to an environmental
acquisition. On the contrary, PA strains identiﬁed in three patients (nr. 2, 4, 5)
presented in cluster with their afﬁnity over the cut off of 85%, thus showing a
potential cross infection accured.
Retrospective analysis of their scheduled clinical visits showed that the three
children were present at the same time in our outpatient clinic since PA in patient 4
was considered eradicated after therapy (repeated negative microbiological cultures).
Conclusion: Our study highlights the possibility of cross infection among not
expectorating children aged less than 24 months. Further studies are needed to
clarify the risk of cross infection also in the ﬁrst years of life. Our results also
showed that much more attention needs to be paid to segregation measures for not
colonized patients, in order to reduce the risk of cross-infection.
